143 related articles for article (PubMed ID: 36233527)
1. Silodosin Improves Pain and Urinary Frequency in Bladder Pain Syndrome/Interstitial Cystitis Patients.
Abreu-Mendes P; Araújo-Silva B; Charrua A; Cruz F; Pinto R
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233527
[TBL] [Abstract][Full Text] [Related]
2. Daily low dose of tadalafil improves pain and frequency in bladder pain syndrome/interstitial cystitis patients.
Mendes PA; Dias N; Simaes J; Dinis P; Cruz F; Pinto R
Turk J Urol; 2022 Jan; 48(1):82-87. PubMed ID: 35118993
[TBL] [Abstract][Full Text] [Related]
3. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
Jhang JF; Wu SY; Lin TY; Kuo HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
[TBL] [Abstract][Full Text] [Related]
4. First-line treatment posterior tibial nerve stimulation in patients with interstitial cystitis/bladder pain syndrome.
Kabay S; Kabay SC; Sevim M
Cent European J Urol; 2021; 74(2):208-214. PubMed ID: 34336240
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
[TBL] [Abstract][Full Text] [Related]
7. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
Jhang JF; Lin TY; Kuo HC
Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
[TBL] [Abstract][Full Text] [Related]
8. Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome.
Sönmez MG; Kozanhan B
Ginekol Pol; 2017; 88(2):61-67. PubMed ID: 28326514
[TBL] [Abstract][Full Text] [Related]
9. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis/bladder pain syndrome-A prospective, multicenter, randomized, double-blind, placebo-controlled study.
Chuang YC; Meng E; Chancellor M; Kuo HC
Neurourol Urodyn; 2020 Jun; 39(5):1505-1514. PubMed ID: 32394478
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.
Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E
Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022
[TBL] [Abstract][Full Text] [Related]
11. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial.
Ko KJ; Cho WJ; Lee YS; Choi J; Byun HJ; Lee KS
Eur Urol; 2020 May; 77(5):644-651. PubMed ID: 31959549
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
Jiang YH; Jhang JF; Lee CL; Kuo HC
Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
[TBL] [Abstract][Full Text] [Related]
16. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
17. Changes in uroplakin expression in the urothelium of patients with ulcerative interstitial cystitis/bladder pain syndrome.
Cho KJ; Lee KS; Choi JB; Koh JS; Kim JC
Investig Clin Urol; 2020 May; 61(3):304-309. PubMed ID: 32377607
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
19. Increased Transient Receptor Potential Melastatin 8 Expression in the Development of Bladder Pain in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
Wu L; Zhang J; Zhou F; Zhang P
Urology; 2020 Dec; 146():301.e1-301.e6. PubMed ID: 33045289
[TBL] [Abstract][Full Text] [Related]
20. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
